Journal:
:archives of clinical infectious diseases
0
majid marjani clinical tuberculosis and epidemiology research center, nritld, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, ir iran; clinical tuberculosis and epidemiology research center, national research institute of tuberculosis and lung disease, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, ir iran. tel.: +98-2126109590, fax: +98-2126109590
payam tabarsi clinical tuberculosis and epidemiology research center, nritld, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, ir iran
parvaneh baghaei clinical tuberculosis and epidemiology research center, nritld, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, ir iran
masoud shamaei clinical tuberculosis and epidemiology research center, nritld, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, ir iran
pegah gorgi biani clinical tuberculosis and epidemiology research center, nritld, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, ir iran
davood mansouri clinical tuberculosis and epidemiology research center, nritld, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, ir iran
results the incidence of diagnosed thrombo-embolic complication was 32 of 1,153 admitted patients (2.8%; 95% confidence interval: 1.9 to 3.9) with a median interval of 14 days after anti-tb treatment initiation. the incidence of dvt and pte was 2% and 1%, respectively. thrombo-embolic events and dvt were more common in men than in women: 4.2% versus 1.3% (p = 0.003) and 3.5% versus 0.4%, respec...